Table 2 Ordinal regression analysis of the influence of clinical phenodata on the favorable functional status (0–2 at mRS) of all patients at discharge and on 90th day of stroke.
Coefficients | At discharge | At 90th day after MT | ||||
|---|---|---|---|---|---|---|
OR | 95% CI | p-value | OR | 95% CI | p-value | |
Age | 0.957 | (0.938–0.976) | 0.000 | 0.960 | (0.943–0.976) | 0.000 |
Female sex | 0.614 | (0.388–0.967) | 0.036 | 0.919 | (0.629–1.339) | 0.661 |
NIHSS1 | 0.853 | (0.813–0.893) | 0.000 | 0.894 | (0.861–0.925) | 0.000 |
AF | 1.374 | (0.827–2.282) | 0.219 | 1.553 | (1.029–2.359) | 0.037 |
Arterial hypertension | 1.034 | (0.616–1.754) | 0.900 | 1.379 | (0.893–2.140) | 0.148 |
DM | 0.505 | (0.286–0.865) | 0.015 | 0.759 | (0.500–1.149) | 0.193 |
Atherosclerosis | 1.356 | (0.839–2.192) | 0.213 | 0.981 | (0.660–1.461) | 0.926 |
Smoking | 1.034 | (0.801–1.334) | 0.798 | 0.984 | (0.798–1.213) | 0.879 |
Dyslipidemia | 1.177 | (0.770–1.792) | 0.448 | 1.034 | (0.733–1.458) | 0.850 |
IVT | 0.854 | (0.541–1.351) | 0.497 | 1.539 | (1.051–2.262) | 0.027 |
ICA | 0.996 | (0.230–4.259) | 0.996 | 0.547 | (0.161–1.826) | 0.327 |
ACA | 0.814 | (0.200–2.712) | 0.752 | 0.595 | (0.210–1.669) | 0.321 |
MCA | 2.388 | (1.040–5.521) | 0.040 | 1.296 | (0.649–2.616) | 0.465 |
VA | 0.643 | (0.155–2.404) | 0.524 | 0.497 | (0.154–1.642) | 0.243 |
BA | 1.555 | (0.486–4.759) | 0.444 | 0.897 | (0.338–2.396) | 0.827 |
PA | 4.873 | (1.403–16.461) | 0.011 | 1.556 | (0.511–5.055) | 0.444 |
mTICI 2b–3 | 1.312 | (0.660–1.813) | 0.002 | 0.792 | (0.871–0.921) | 0.002 |
Time from symptoms to MT | 0.996 | (0.993–0.998) | 0.001 | 0.998 | (0.996–1.000) | 0.114 |
MT time | 0.986 | (0.980–0.992) | 0.000 | 0.989 | (0.984–0.994) | 0.000 |
ICH | 0.751 | (0.147–1.513) | 0.022 | 0.312 | (0.311–0.864) | 0.039 |
DH | 0.217 | (0.210–1.171) | 0.037 | 1.214 | (1.047–2.314) | 0.026 |